Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study
- 1 November 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 25 (11) , 2317-2324
Abstract
Objectives To define the prevalence of microalbuminuria (MAU) in hypertensive outpatients attending a cardiologist or internist (i-SEARCH A) and to compare hypertensive outpatients with or without coronary artery disease (CAD; i-SEARCH B). A secondary objective was to establish a correlation between MAU and known cardiovascular risk factors. Methods i-SEARCH was an international, observational study. which enrolled consecutive outpatients with hypertension. Patients with reasons for a false-positive MAU test were excluded. Main outcome measures were the prevalence of MAU as assessed using a dipstick test, hypertension co-morbidities, co-medication and presence of known cardiovascular risk factors. Results A total of 21 050 patients, from 26 countries, were included in the primary analysis. Overall prevalence of MAU was 58.4% (men > women), although there was considerable variation in prevalence across countries and continents (maximum 71% in Vietnam/Indonesia; minimum 53% in Germany/Switzerland). In multivariate analyses, predictors of MAU were identified to be male gender, high waist circumference, systolic blood pressure ≥ 120 mmHg, diastolic blood pressure ≥ 100 mmHg, creatinine clearance ≥ 50 ml/min, and the presence of diabetes, congestive heart failure, CAD, history of cerebral pathology, peripheral arterial disease, dyspnoea or palpitations. MAU was present more often in patients with CAD than in patients without. Conclusions MAU is extremely common in hypertensive outpatients worldwide, especially in patients with known cardiovascular risk factors. Given its importance as a strong, early and independent marker of increased cardiovascular risk in hypertension, the results of i-SEARCH mandate more rigorous MAU screening of hypertensive patients in clinical practice.Keywords
This publication has 31 references indexed in Scilit:
- Impaired Coronary Endothelium–Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary ArteriesDiabetes Care, 2006
- Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction—The Hoorn StudyKidney International, 2004
- Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC‐Norfolk) population studyJournal of Internal Medicine, 2004
- Prognostic value of endothelial functionThe American Journal of Cardiology, 2003
- Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or ProteinuriaDiabetes Care, 2003
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart DiseaseHypertension, 2000
- Microalbuminuria and endothelial dysfunction in essential hypertensionThe Lancet, 1994
- Albuminuria reflects widespread vascular damageDiabetologia, 1989